Combined Screening for Gastrointestinal Tumors

RecruitingOBSERVATIONAL
Enrollment

200,000

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Gastrointestinal Tumors
Interventions
DIAGNOSTIC_TEST

questionnaire, Helicobacter pylori (H. pylori) test, fecal immunochemical test (FIT)

The questionnaire covers nine aspects: basic information of the participants, symptoms and previous examinations, medical history and surgical history, medication history, smoking history, alcohol consumption history, dietary habits, physical exercise, and family history.

Trial Locations (2)

315500

RECRUITING

Fenghua District, Ningbo

321300

RECRUITING

Yongkang City, Jinhua

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fenghua District People's Hospital, Ningbo City

UNKNOWN

collaborator

Fenghua District Traditional Chinese Medicine Hospital, Ningbo City

UNKNOWN

collaborator

Xikou Hospital in Fenghua District, Ningbo City

UNKNOWN

collaborator

Yongkang Traditional Chinese Medicine Hospital

UNKNOWN

collaborator

Hangzhou Medical College

OTHER

lead

Zhejiang Cancer Hospital

OTHER

NCT06478030 - Combined Screening for Gastrointestinal Tumors | Biotech Hunter | Biotech Hunter